In a surprising post on Truth Social, Trump raises doubts about the Covid vaccines developed during his presidency, demanding transparency from drug companies amid ongoing CDC turmoil.
In a bold move, President Trump calls for pharmaceutical companies to justify the success of their Covid drugs amid a leadership crisis at the CDC. As the FDA tightens vaccine eligibility, tensions rise over vaccine efficacy and public health transparency.
AstraZeneca's FluMist Home, a nasal flu vaccine available for at-home use, aims to improve vaccination rates among children, especially those afraid of needles. Experts discuss its effectiveness and accessibility.
HHS Secretary Robert F. Kennedy Jr. has sparked outrage by canceling $500 million in mRNA vaccine research grants, citing questionable data. Experts warn this could hinder public health efforts and the future of vaccine technology.
The newly appointed vaccine advisory committee by Health Secretary Robert F. Kennedy Jr. is set to review childhood immunization practices, raising concerns among health experts about the implications for public health.
The Nimbus variant is causing a stir with familiar COVID-19 symptoms and a surge in painful sore throats. Experts weigh in on its spread and vaccine efficacy. Stay informed and protected!
Moderna's combined Covid and flu vaccine has outperformed traditional shots in a recent phase 3 trial, generating higher antibody levels and showing promise for dual protection against both viruses.
In a groundbreaking move, HHS Secretary Robert F. Kennedy Jr. mandates new vaccines to undergo placebo testing, raising ethical questions and altering vaccine approval protocols. Is this the future of vaccine safety?
A measles outbreak in Texas has infected nearly 280 people across 15 states, marking the largest outbreak in 30 years. Health officials warn of more cases as communities respond to the crisis.
